Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Lung Cancer

Free Subscription Articles published in J Cancer Res Clin Oncol Retrieve available abstracts of 34 articles: HTML format Text format

Single Articles

March 2010
1. LEE YJ , Shim HS, Kang YA, Hong SJ, et al
   Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.
   J Cancer Res Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
2. JIAN G , Songwen Z, Ling Z, Qinfang D, et al
   Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer.
   J Cancer Res Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. DANG J , Li G, Lu X, Yao L, et al
   Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
   J Cancer Res Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. HUANG G , Chen L
   Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma.
   J Cancer Res Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SITU D , Long H, Lin P, Zhu Z, et al
   Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma.
   J Cancer Res Clin Oncol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
6. HE XY , Chen JX, Zhang Z, Li CL, et al
   The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.
   J Cancer Res Clin Oncol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. LEE YJ , Park IK, Park MS, Choi HJ, et al
   Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma.
   J Cancer Res Clin Oncol. 2009;135:1647-54.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
8. TU ML , Wang HQ, Chen LJ, Lu JC, et al
   Involvement of Akt1/protein kinase Balpha in tumor conditioned medium-induced endothelial cell migration and survival in vitro.
   J Cancer Res Clin Oncol. 2009;135:1543-50.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. CARLSON JJ , Garrison LP, Ramsey SD, Veenstra DL, et al
   Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis.
   J Cancer Res Clin Oncol. 2009;135:1483-93.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2009
10. LIN Q , Geng J, Ma K, Yu J, et al
    Erratum to: RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles   
    
    
    September 2009
11. YOSHIDA K , Yatabe Y, Park J, Ogawa S, et al
    Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. PARK KS , Kim HK, Lee JH, Choi YB, et al
    Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. ZHANG C , Zhu H, Yang X, Lou J, et al
    P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
14. LIU CY , Wang YM, Wang CL, Feng PH, et al
    Population alterations of L: -arginase- and inducible nitric oxide synthase-expressed CD11b(+)/CD14 (-)/CD15 (+)/CD33 (+) myeloid-derived suppressor cells and CD8 (+) T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
15. LIN Q , Geng J, Ma K, Yu J, et al
    RASSF1A, APC, ESR1, ABCB1 and HOXC9, but not p16INK4A, DAPK1, PTEN and MT1G genes were frequently methylated in the stage I non-small cell lung cancer in China.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. LI X , Zhang Q, Cai L, Wang Y, et al
    Inhibitor of growth 4 induces apoptosis in human lung adenocarcinoma cell line A549 via Bcl-2 family proteins and mitochondria apoptosis pathway.
    J Cancer Res Clin Oncol. 2009;135:829-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
17. XIAO L , Luxi S, Ying T, Yizhi L, et al
    Diagnosis of unknown nonhematological tumors by bone marrow biopsy: a retrospective analysis of 10,112 samples.
    J Cancer Res Clin Oncol. 2009;135:687-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
18. WILOP S , von Hobe S, Crysandt M, Esser A, et al
    Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
19. TOMIDA M , Mikami I, Takeuchi S, Nishimura H, et al
    Serum levels of nicotinamide N-methyltransferase in patients with lung cancer.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
20. SEGAWA Y , Takata S, Fujii M, Oze I, et al
    Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. CHOI YJ , Rho JK, Lee SJ, Jang WS, et al
    HIF-1alpha modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines.
    J Cancer Res Clin Oncol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. STRUMANE K , Rygiel T, van der Valk M, Collard JG, et al
    Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
    J Cancer Res Clin Oncol. 2009;135:69-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. NASHAN D , Muller ML, Braun-Falco M, Reichenberger S, et al
    Cutaneous metastases of visceral tumours: a review.
    J Cancer Res Clin Oncol. 2009;135:1-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
24. YANG TM , Leu SW, Li JM, Hung MS, et al
    WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.
    J Cancer Res Clin Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. HIGGINBOTHAM KB , Lozano R, Brown T, Patt YZ, et al
    A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
    J Cancer Res Clin Oncol. 2008;134:1325-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
26. XU JM , Han Y, Duan HQ, Gao EM, et al
    EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib.
    J Cancer Res Clin Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ZIMMER S , Kahl P, Buhl TM, Steiner S, et al
    Epidermal growth factor receptor mutations in non-small cell lung cancer influence downstream Akt, MAPK and Stat3 signaling.
    J Cancer Res Clin Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
28. WANG CL , Sun BS, Tang Y, Zhuang HQ, et al
    CCR1 knockdown suppresses human non-small cell lung cancer cell invasion.
    J Cancer Res Clin Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. ELKIN AD , Jacobs CD
    Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases.
    J Cancer Res Clin Oncol. 2008;134:1151-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
30. GIACCONE G , Iacona RB, Fandi A, Janas M, et al
    Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy.
    J Cancer Res Clin Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. MAEDA T , Hashitani S, Zushi Y, Segawa E, et al
    Establishment of a nude mouse transplantable model of a human malignant fibrous histiocytoma of the mandible with high metastatic potential to the lung.
    J Cancer Res Clin Oncol. 2008;134:1005-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. VRZALIKOVA K , Skarda J, Ehrmann J, Murray PG, et al
    Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study.
    J Cancer Res Clin Oncol. 2008;134:1037-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
33. SASAKI H , Okuda K, Shimizu S, Takada M, et al
    EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.
    J Cancer Res Clin Oncol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
34. ABDEL-AZIZ HO , Murai Y, Takasaki I, Tabuchi Y, et al
    Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study.
    J Cancer Res Clin Oncol. 2008;134:777-88.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: